Evidence map›Paper›PMID 37963764›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2024

Role of the Glycine Receptor β Subunit in Synaptic Localization and Pathogenicity in Severe Startle Disease.

Anna-Lena Wiessler, Ann-Sofie Hasenmüller, Isabell Fuhl, Clémence Mille, Orlando Cortes Campo, Nicola Reinhard, Joachim Schenk, Katrin G Heinze, Natascha Schaefer, Christian G Specht and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Competition between glycine and GABAProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Anna-Lena WiesslerInstitute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University of Würzburg, 97078 Würzburg, Germany.
Ann-Sofie HasenmüllerInstitute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University of Würzburg, 97078 Würzburg, Germany.
Isabell FuhlInstitute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University of Würzburg, 97078 Würzburg, Germany.
Clémence MilleInstitut National de la Santé et de la Recherche Médicale (Inserm U1195), Université Paris-Saclay, 94276 Le Kremlin-Bicêtre, France.
Orlando Cortes CampoInstitute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University of Würzburg, 97078 Würzburg, Germany.
Nicola ReinhardInstitute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University of Würzburg, 97078 Würzburg, Germany.
Joachim SchenkRudolf Virchow Center for Integrative and Translational Bioimaging, Julius-Maximilians-University of Würzburg, 97080 Würzburg, Germany.
Katrin G HeinzeRudolf Virchow Center for Integrative and Translational Bioimaging, Julius-Maximilians-University of Würzburg, 97080 Würzburg, Germany.
Natascha SchaeferInstitute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University of Würzburg, 97078 Würzburg, Germany.ORCID 0000-0001-9743-1963
Christian G SpechtInstitut National de la Santé et de la Recherche Médicale (Inserm U1195), Université Paris-Saclay, 94276 Le Kremlin-Bicêtre, France villmann_c@ukw.de christian.specht@inserm.fr.
Carmen VillmannInstitute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University of Würzburg, 97078 Würzburg, Germany villmann_c@ukw.de christian.specht@inserm.fr.ORCID 0000-0003-1498-6950
University of Würzburg · DEInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Startle disease is due to the disruption of recurrent inhibition in the spinal cord. Most common causes are genetic variants in genes (

Indexed as

Receptors, GlycineSpinal CordAdultAnimalsGlycineHumansMiceSynaptic TransmissionVirulenceGLRB protein, humanGlycineReceptors, Glycineglycine receptorinhibitory synapsemouse modeloscillatorshakystartle disease

Identifiers

PMID37963764
PMCPMC10860499
OpenAlexW4388666972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.